Literature DB >> 322133

Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule.

R L Ceriani, K Thompson, J A Peterson, S Abraham.   

Abstract

Rabbit antibodies against components of the human milk fat globule bind specifically to normal human breast epithelial cells and cell lines derived from breast carcinomas, as well as to the outer surface of the human milk fat globule. Variation in indirect immunofluorescence staining in both intensity per cell and percentage of cells stained is observed for the different brest cell lines. Cells derived from other epithelial and other ectodermal tissues, fetal fibroblasts, cells of the blood buffy coat, and even fibroblasts of the breast itself do not bind the antibodies. This suggests that these antibodies are detecting cell-type-specific antigens. These normal breast epithelial cell antigens are on the cell surface and their expression is stable in long-term cultured cell lines, even after much chromosomal variation in a given line. By affinity chromatography, three distinct antigenic components can be isolated from the milk fat globule, one of which contains carbohydrate. These differentiation antigens of the human breast epithelial cell are not only useful as specific cell-type markers, but also can provide a tool to study the role of the cell surface in normal and neoplastic mammary development.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322133      PMCID: PMC392335          DOI: 10.1073/pnas.74.2.582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Distinctive banded marker chromosomes of human tumor cell lines.

Authors:  W A Nelson-Rees; R R Flandermeyer; P K Hawthorne
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Studies on milk fat globule membranes.

Authors:  R M Dowben; J R Brunner; D E Philpott
Journal:  Biochim Biophys Acta       Date:  1967-02-01

Review 4.  The H-2 model for the major histocompatibility systems.

Authors:  J Klein; D C Shreffler
Journal:  Transplant Rev       Date:  1971

5.  The use of affinity chromatography for the specific purification of antibodies and antigens.

Authors:  L Wofsy; B Burr
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

6.  Immunologic methods for the identification of cell types. I. Specific antibodies that distinguish between mammary gland epithelial cells and fibroblasts.

Authors:  K Thompson; R L Ceriani; D Wong; S Abraham
Journal:  J Natl Cancer Inst       Date:  1976-07       Impact factor: 13.506

Review 7.  Reviews of the progress of dairy science. Section A. Physiology. Hormonal control of lactogenesis.

Authors:  R Denamur
Journal:  J Dairy Res       Date:  1971-06       Impact factor: 1.904

8.  Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor.

Authors:  S von Kleist; E Chany; P Burtin; M King; J Fogh
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

9.  Establishment of a cell line (SH-4) from pleural effusion of a patient with melanoma.

Authors:  G Seman; S J Hunter; J M Lukeman; L Dmochowski
Journal:  In Vitro       Date:  1975 Jul-Aug

10.  Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity.

Authors:  S H Golub; D C Hanson; H L Sulit; D L Morton; M A Pellegrino; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1976-01       Impact factor: 13.506

View more
  53 in total

1.  Overview of new treatments for breast cancer.

Authors:  G N Hortobagyi
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  The removal of cell surface material by enzymes used to dissociate mammary-gland cells.

Authors:  R L Ceriani; J A Peterson; S Abraham
Journal:  In Vitro       Date:  1978-11

3.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

4.  Lectin binding sites in cultured human breast cancer cells.

Authors:  E Müller-Holzner; C Marth; E Kofler; G Daxenbichler; F Hofstädter
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Antibodies to normal human colon membranes: preparation, characterization and tissue distribution.

Authors:  R J Nicholls; J Southgate; L K Trejdosiewicz
Journal:  Histochem J       Date:  1985-06

6.  Circulating human mammary epithelial antigens in breast cancer.

Authors:  R L Ceriani; M Sasaki; H Sussman; W M Wara; E W Blank
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Membrane 126-kilodalton phosphoglycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells.

Authors:  H R Soule; E Linder; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  Epitope expression on the breast epithelial mucin.

Authors:  R L Ceriani; J A Peterson; E W Blank; D T Lamport
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Breast cancer markers: comparison between sialyltransferase and human mammary epithelial antigens (HME-Ags) for the detection of human breast tumors grafted in nude mice.

Authors:  M Sasaki; S Barber; R L Ceriani
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

10.  The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.

Authors:  R A Newman; P J Klein; G Uhlenbruck; P Citoler; D Karduck
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.